Focus On Bioengineering Research

Image
Researcher looking through microscope lense. Focus On Bioengineering ban

Bioengineering applications may be funded by NINDS if they focus on technology development relevant to normal or disordered neural function and to the prevention, repair or replacement of compromised neural function. Funded applications include partnerships that span academic entities (biological, bioengineering, biomedical groups), device industries, commercial distribution companies, medical instrument companies, small business concerns, etc. Final stages of translation for FDA investigational device exemption (IDE) and early-stage clinical trials might be a candidate for one of the NINDS cooperative agreement programs. To search the bioengineering projects funded at NIH please go to NIH RePORTER, or select bioengineering research in the categorical spending. Many of the NINDS funded bioengineering research focuses on neural interfaces, including neuroprostheses, neuromodulation, brain-computer interface (BCI) devices, prosthetic control, and neural interface technology development.

 

Estimates of Funding for Various Research, Condition, and Disease Categories

Research/Disease Areas* FY 2016
(Actual)
FY 2017
(Actual)
FY 2018
Estimated
(Enacted)
FY 2019
Estimated
Bioengineering $3,841 $4,106 $4,420 $4,110
Biomedical Imaging $1,361 $2,083 $2,242 $2,089
Nanotechnology $398 $444 $475 $440
Biotechnology $6,433 $6,556 $7,012 $6,491
Assistive Technology $296 $299 $316 $287

*Dollars in millions and rounded
 

Proceedings & Outcomes

Resources and Tools

Contacts

Nick Langhals, Ph.D. | Program Director, Neural Engineering
nick.langhals@nih.gov

Sahana Kukke, Ph.D.|Program Director
sahana.kukke@nih.gov

Kari Ashmont, Ph.D. | Health Program Specialist
kari.ashmont@nih.gov

Funding Opportunities 

BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human CNS (UG3/UH3) NS-17-005; (U44 for Small Businesses) NS-17-007

BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human CNS (UH3) NS-17-006

News & Events

Waterlogged brain region helps scientists gauge damage caused by Parkinson’s disease

 

Related Topics 

FDA resources and guidance on Neurological Devices
The BRAIN Initiative webinar series consists of 30 minute presentations from BRAIN-funded investigators developing recording and modulation technologies.

BRAIN Initiative Webinar Series
The BRAIN Initiative webinar series consists of 30 minute presentations from BRAIN-funded investigators developing recording and modulation technologies.

Best Practices for Navigating the Pre-submission process with FDA

FDA Regulation of Neurological and Physical Medicine Devices: Access to Safe and Effective Neurotechnologies for All Americans